Waters Co. (NYSE:WAT) Shares Bought by Quent Capital LLC

Quent Capital LLC lifted its stake in Waters Co. (NYSE:WAT) by 41.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 229 shares of the medical instruments supplier’s stock after acquiring an additional 67 shares during the period. Quent Capital LLC’s holdings in Waters were worth $85,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Kennebec Savings Bank acquired a new stake in shares of Waters in the 3rd quarter worth approximately $33,000. Fortitude Family Office LLC raised its holdings in shares of Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Waters in the 3rd quarter worth approximately $35,000. R Squared Ltd bought a new stake in shares of Waters in the 4th quarter worth approximately $63,000. Finally, Itau Unibanco Holding S.A. raised its holdings in shares of Waters by 63.2% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 72 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Down 5.6 %

Waters stock opened at $382.45 on Thursday. The firm has a market cap of $22.71 billion, a PE ratio of 36.49, a P/E/G ratio of 7.37 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The firm’s 50 day moving average price is $390.16 and its two-hundred day moving average price is $363.86. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.43% and a return on equity of 49.93%. On average, research analysts predict that Waters Co. will post 11.79 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WAT has been the topic of a number of research reports. Stifel Nicolaus boosted their target price on shares of Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Scotiabank initiated coverage on shares of Waters in a report on Monday, December 23rd. They issued a “sector perform” rating and a $430.00 target price on the stock. TD Cowen boosted their target price on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Bank of America boosted their target price on shares of Waters from $400.00 to $430.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Finally, Barclays upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $360.00 to $415.00 in a report on Monday. Ten research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $388.64.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.